Get the Stockscreener App
19.95
2.83%
-0.54
Optimizerx Corp stock is traded at $19.95, with a volume of 165.86K.
It is down -2.83% in the last 24 hours and up +6.18% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$20.49
Open:
$20.49
24h Volume:
165.86K
Relative Volume:
0.46
Market Cap:
$369.26M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-24.94
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
-4.65%
1M Performance:
+6.18%
6M Performance:
+98.10%
1Y Performance:
+286.59%
1-Day Range:
$19.54
$21.09
1-Week Range:
$19.50
$21.56
52-Week Range:
$3.78
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
19.89 | 380.40M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
291.73 | 47.73B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.67 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.95 | 12.36B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.52 | 8.15B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.20 | 6.86B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
Can a trend reversal in OptimizeRx Corporation lead to recoveryEarnings Risk Summary & Long-Term Safe Return Strategies - newser.com
Will OptimizeRx Corporation stock recover faster than market2025 Volume Leaders & Daily Price Action Insights - newser.com
What analyst consensus says on OptimizeRx Corporation stockMarket Risk Analysis & Long-Term Safe Investment Ideas - newser.com
Is now a turning point for OptimizeRx CorporationQuarterly Trade Report & AI Forecasted Entry and Exit Points - newser.com
Will OptimizeRx Corporation stock deliver better than expected guidanceWeekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
Why OptimizeRx Corporation stock appeals to analysts2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
Can OptimizeRx Corporation stock attract ESG capital inflows2025 Technical Patterns & Technical Confirmation Alerts - newser.com
OptimizeRx Corporation (OPRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
OptimizeRx (OPRX) to Release Earnings on Thursday - MarketBeat
OptimizeRx Corporation stock chart pattern explained2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Why OptimizeRx Corporation stock attracts global investorsMarket Performance Report & Verified Stock Trade Ideas - newser.com
OptimizeRx (NASDAQ: OPRX) sets Q2 results call Aug 7 via webcast and dial-in access - Stock Titan
OptimizeRx Corp. Hits New 52-Week High of $21.99, Up 90% Yearly - Markets Mojo
OptimizeRx Corporation stock outlook for YEARWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com
What insider trading reveals about OptimizeRx Corporation stockPortfolio Value Report & Capital Efficient Trade Techniques - Fundação Cultural do Pará
Aug Outlook: Why OptimizeRx Corporation stock appeals to analystsJobs Report & Free Safe Capital Growth Stock Tips - fcp.pa.gov.br
Is OptimizeRx Corporation stock in correction or buying zoneGold Moves & Daily Volume Surge Trade Alerts - Fundação Cultural do Pará
Why analysts upgrade OptimizeRx Corporation stockEarnings Overview Summary & Safe Capital Preservation Plans - fcp.pa.gov.br
Is OptimizeRx Corporation stock recession proofJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
RBC Capital Downgrades OptimizeRx (OPRX) - MSN
OptimizeRx Stock Delivers Over 90% Gain In Six MonthsA Prescription For Portfolio Growth? - RTTNews
Pattern recognition hints at OptimizeRx Corporation upsideStock Surge & Reliable Momentum Entry Alerts - newser.com
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
6.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):